1.015USD-1.46%Mkt Cap: 272.28M USDP/E: —Last update: 2026-06-01
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypo…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap272.28M USD
Enterprise Value308.50M USD
Revenue (TTM)232.40M USD
Gross Profit196.73M USD
Net Income (TTM)-5.34M USD
Revenue/Share0.8770 USD
Last Price1.015 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees194
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS00972D1054
Valuation
P/E (Trailing)—
P/E (Forward)-5.37
PEG—
EV/EBITDA25.43
EV/Revenue1.33
P/S1.18
P/B10.00
EPS (TTM)-0.08
EPS (Forward)-0.19
52W Range
0.87504% of range4.079
52W High4.079 USD
52W Low0.8750 USD
Profitability
Gross Margin83.29%
Oper. Margin-2.76%
EBITDA Margin5.22%
Profit Margin-2.26%
ROE-16.39%
ROA-1.42%
Growth
Revenue Growth-6.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF67.99M USD
CapEx (TTM)8.10M USD
FCF Margin28.32%
FCF Yield24.17%
Net Debt34.88M USD
Net Debt/EBITDA2.88
Balance Sheet
Debt/Equity1.59
Current Ratio1.40
Quick Ratio1.29
Book Value/Sh0.1020 USD
Cash/Share0.6060 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)4.200 USD
Target Range3.000 USD – 6.000 USD
# Analysts5
Ownership
Shares Out.268.26M
Float262.29M
Insiders4.00%
Institutions42.12%
Short Interest
Short Ratio7.5d
Short % Float9.98%
Short % Out.9.83%
Shares Short26.37M
Short (prev mo.)27.31M
Technical
SMA 501.312 (-22.6%)
SMA 2001.873 (-45.8%)
Beta0.35
S&P 52W Chg27.94%
Avg Vol (30d)4.26M
Avg Vol (10d)6.64M
Technical Indicators
RSI (14)37.4
MACD-0.0926
MACD Signal-0.0920
MACD Hist.-0.0006
BB Upper1.499 USD
BB Middle1.149 USD
BB Lower0.7989 USD
BB Width60.95%
ATR (14)0.0792 USD
Vol Ratio (20d)0.34x